
Feature|Videos|July 16, 2025
Designing Effective Value-Based Contracts: Timing, Evidence, and Risk Alignment
Industry experts react to the developer’s role in preparing for value-based contracting, acknowledging that innovative agreements can support access when evidence is still maturing.
Advertisement
Episodes in this series

There is no shortcut to executing a value-based contract. In this episode, experts lay out what’s required to bring these agreements to life: evidence alignment, data compatibility, and mutual incentive. Payers want results, not just risk transference—and developers must understand and speak to payer business goals.
Key discussion topics include:
- Timeline and prerequisites for executing value-based contracts.
- Understanding what matters to payers vs. regulators.
- How to prototype contracting models for early feedback.
- The importance of strong head-to-head clinical data as the foundation.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Have 503B Outsourcing Facilities Truly Reduced US Drug Shortages?
2
CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program, Including First-Ever Part B Drugs
3
Pharma Pulse: HHS Bypasses PBMs and the Reality of GLP-1 Weight Regain
4
Morris & Dickson Acquires Prodigy Health to Expand Specialty and Plasma Distribution Capabilities
5


